San Diego based Sorrento Therapeutics claims that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration which lead to jumps in stocks around 244%.
source https://www.pharmatutor.org/pharma-news/2020/usa-based-sorrento-therapeutics-claims-breakthrough-against-covid-19-shares-jumps-around-244-percent
No comments:
Post a Comment